Brunicardi; F. Charles

Patent Applications and Registrations

Patent applications and USPTO patent grants for Brunicardi; F. Charles.The latest application filed is for "micropatterned silicone oxygenating dressing for chronic wounds".

Company Profile

0.6.9

Brunicardi; F. Charles - Pacific Palisades CA
Brunicardi; F. Charles - Toledo OH
Brunicardi; F. Charles - Houston TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
High definition, color images, animations, and videos for diagnostic and personal imaging applications Grant 11,051,769 - Brunicardi July 6, 2	2021-07-06
Micropatterned Silicone Oxygenating Dressing For Chronic Wounds App 20210001001 - Das; Chandan ; et al.	2021-01-07
High Definition, Color Images, Animations, And Videos For Diagnostic And Personal Imaging Applications App 20190090824 - Brunicardi; F. Charles	2019-03-28
Therapeutic RNA interference technology targeted to the PDX-1 oncogene in PDX-1 expressing neuroendocrine tumors Grant 9,133,459 - Nemunaitis , et al. September 15, 2	2015-09-15
BI-FUNCTIONAL shRNA TARGETING MESOTHELIN AND USES THEREOF App 20130259926 - Rao; Donald ; et al.	2013-10-03
Novel Therapeutic RNA Interference Technology Targeted to the PDX-1 Oncogene in PDX-1 Expressing Neuroendocrine Tumors App 20130084331 - Nemunaitis; John J. ; et al.	2013-04-04
Therapeutic RNA interference technology targeted to the PDX-1 oncogene in PDX-1 expressing neuroendocrine tumors Grant 8,361,983 - Nemunaitis , et al. January 29, 2	2013-01-29
Treating Insulin Secreting Cells App 20110257250 - Brunicardi; F. Charles	2011-10-20
Novel Therapeutic RNA Interference Technology Targeted to the PDX-1 Oncogene in PDX-1 Expressing Neuroendocrine Tumors App 20110117183 - Nemunaitis; John J. ; et al.	2011-05-19
Treating hyperinsulinemia by killing beta cells with cytotoxic gene App 20050137157 - Brunicardi, F. Charles	2005-06-23
Promoter driven tissue specific cytotoxic agents and title methods of use App 20050059620 - Brunicardi, F. Charles	2005-03-17
Treatment of pancreatic adenocarcinoma by cytotoxic gene therapy Grant 6,716,824 - Brunicardi April 6, 2	2004-04-06

Company Registrations

SEC

0001670258

Brunicardi F. Charles

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.